InscoBi is focusing its capabilities on the bio business sector as it resumes production of Apitoxin, a natural product-derived osteoarthritis pain treatment, through its new drug development ...
InscoBio, a KOSPI-listed company (CEO Insoo Yoo and Jagap Koo), announced on the 17th that it has obtained approval from the Ministry of Food and Drug Safety (MFDS) for the resale of ‘Apitoxin,’ a ...
Bienengift gegen Schmerzen? Das klingt im ersten Moment etwas widersprüchlich. Denn angesichts der Bezeichnung “Gift” dürfte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results